Workflow
Neotech Metals Announces Amended LIFE Financing
aTyr PharmaaTyr Pharma(US:LIFE) Newsfileยท2024-08-14 01:54

Core Viewpoint - Neotech Metals Corp. has amended the terms of its non-brokered private placement LIFE financing, aiming to raise between $1,350,000 and $2,500,000 through the issuance of units priced at $0.15 each, which include common shares and warrants [1][5]. Group 1: Offering Details - The offering will consist of a minimum of 9,000,000 units and up to a maximum of 16,666,667 units, with each unit comprising one common share and one warrant [1]. - Each warrant allows the holder to purchase an additional common share at a price of $0.25 for a period of 36 months from issuance [1]. - An acceleration provision is included, allowing the company to shorten the expiry date of the warrants to 30 days if the closing price of the common shares exceeds $0.50 for 10 consecutive trading days [2]. Group 2: Compensation and Regulatory Compliance - The company may pay finders a cash commission of up to 7% of the total gross proceeds raised and issue finder's warrants equivalent to 7% of the total units subscribed [3]. - The offering will be available to purchasers in all provinces of Canada except Quebec, under the listed issuer financing exemption, and the securities will not be subject to resale restrictions [4]. Group 3: Use of Proceeds - The net proceeds from the offering will be allocated for exploration expenditures and general corporate operating expenses [5]. Group 4: Company Overview - Neotech Metals Corp. is focused on mineral exploration, particularly in rare earth elements, with properties located in British Columbia and Ontario [6][7].